Ratio of gross profit to total net assets for private limited companies in the pharmaceuticals and medicines manufacturing industry

Annual · percent · 2015–2017 · Published by India — Reserve Bank of India

Latest · 2017

7.8%

unchanged ±0.0 pts vs 2016

High since 2015
7.8% · 2016
Low since 2015
7.6% · 2015

percent

Use this series in your AI

Use FactIQ to chart rbi::rbi|07ff81455674f462 over the last ten years, with its latest value and the change over the past year.

Paste into an AI model with FactIQ connected. How to connect

About this series

This series represents the profitability ratio of earnings before interest and taxes (EBIT) relative to total net assets for non-government non-financial private limited companies. The data specifically focuses on the pharmaceuticals and medicines subgroup within the manufacturing sector as reported in the Reserve Bank of India's historical financial ratios for select private limited companies. (Footnote: Note : 1. Figures in brackets below the industry name represent the number of companies in the industry. 2. For footnotes, please refer to Statement 2 and Statement 7. 3. Industry group, viz., 'Basic Chemicals' and 'Pharmaceuticals & Medicines' are subgroup of 'Chemical and Chemical Products'. 4. Industry group, viz., 'Plastic Products' is the subgroup of 'Rubber and Plastic Products'.)

Series ID
rbi::rbi|07ff81455674f462
Frequency
Annual
Units
percent
Coverage
2015 – 2017
Ratio of gross profit to total net assets for private limited companies in the pharmaceuticals and medicines manufacturing industry: 7.8% for 2017 · FactIQ